Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
22.99
+0.03 (0.14%)
Aug 21, 2025, 4:00 PM - Market closed
THNR Holdings Information
THNR is an equity ETF with a total of 23 individual holdings. The top holdings are Eli Lilly and Company stock at 11.38%, Novo Nordisk at 8.88%, Regeneron Pharmaceuticals at 7.66%, Amgen at 6.96%, and Chugai Pharmaceutical at 5.92%.
Total Holdings
23
Top 10 Percentage
68.33%
Asset Class
Equity
ETF Category
Health
Assets
4.11M
PE Ratio
16.72
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 11.38% |
| 2 | NVO | Novo Nordisk A/S | 8.88% |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 7.66% |
| 4 | AMGN | Amgen Inc. | 6.96% |
| 5 | TYO: 4519 | Chugai Pharmaceutical Co., Ltd. | 5.92% |
| 6 | ABBV | AbbVie Inc. | 5.63% |
| 7 | AZN | AstraZeneca PLC | 5.57% |
| 8 | GILD | Gilead Sciences, Inc. | 5.53% |
| 9 | MRK | Merck & Co., Inc. | 5.45% |
| 10 | PFE | Pfizer Inc. | 5.36% |
| 11 | HKG: 1801 | Innovent Biologics, Inc. | 5.18% |
| 12 | SWX: ROG | Roche Holding AG | 5.05% |
| 13 | HKG: 1093 | CSPC Pharmaceutical Group Limited | 5.04% |
| 14 | TYO: 4507 | Shionogi & Co., Ltd. | 4.46% |
| 15 | HIMS | Hims & Hers Health, Inc. | 3.13% |
| 16 | CPH: ZEAL | Zealand Pharma A/S | 2.60% |
| 17 | VKTX | Viking Therapeutics, Inc. | 1.75% |
| 18 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.68% |
| 19 | HKG: 3933 | The United Laboratories International Holdings Limited | 1.38% |
| 20 | KRX: 128940 | Hanmi Pharm. Co., Ltd. | 0.83% |
| 21 | n/a | DEPOSITS WITH BROKER FOR SHORT POSITIONS | 0.30% |
| 22 | AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | 0.28% |
| 23 | n/a | SOUTH KOREA WON | 0.00% |
As of Aug 19, 2025